SEC Form 4 · accession 0001292445-15-000005
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Breckon
Director
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 8:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 12, 2015 | M | 3,669 | $8.45 | A | 18,613 | D | |
| Class A Common StockF1 | Aug 12, 2015 | F | 705 | $48.20 | D | 17,908 | D | |
| Class A Common StockF2,F3 | Aug 12, 2015 | S | 2,964 | $44.00 | D | 14,944 | D | |
| Class A Common StockF2,F3 | Aug 12, 2015 | S | 5,417 | $44.00 | D | 9,527 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F4 | $8.45 | Aug 12, 2015 | M | 3,669 | D | — | Sep 28, 2020 | Class A Common Stock | 3,669 | 8,071 | D |
Explanation of responses
- F1This is the Fair Market Value as calculated pursuant to the INC Research Holdings, Inc.'s (the "Issuer") 2010 Equity Incentive Plan.
- F2The shares of Class A common stock, $0.01 par value per share (each, a "Share") were sold by the Issuer to Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC (collectively, the "Underwriters") in a registered underwritten secondary offering pursuant to the underwriting agreement dated August 11, 2015 (the "Underwriting Agreement"), entered into by and among the Selling Stockholders (as defined in the Underwriting Agreement) and the Underwriters.
- F3The price represents the offering price of $44.00 per Share of the Issuer.
- F4The Shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued service on the Issuer's Board of Directors.